Trials / Completed
CompletedNCT00548080
Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055)
A Non-Comparative, Multicenter, Open-Label, Study to Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 131 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Registration study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0991, caspofungin acetate / Duration of Treatment: |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2006-11-01
- Completion
- 2006-11-01
- First posted
- 2007-10-23
- Last updated
- 2015-12-17
Source: ClinicalTrials.gov record NCT00548080. Inclusion in this directory is not an endorsement.